EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato‐oncology inpatients: A cohort study

Jenny Welford, Raigan Rafferty, Katherine Hunt, David Short, Louise Duncan, Ann Ward, Christine Rushton, Adam Todd, Smeera Nair, Thomas Hoather, Miranda Clarke, Lydia Dawes und 5 weitere

European Journal of Cancer Care · 2022-11 · 31 (6)

DOI: 10.1111/ecc.13752 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Cancer Care, online erschienen am 26.10.2022. Verfasst von Jenny Welford und 16 weiteren Autor:innen. Beteiligte Einrichtung: Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Frailty. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sir Bobby Robson Foundation, The Newcastle upon Tyne Hospitals NHS Foundation Trust cancer charity, NIHR Newcastle Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Routinely used performance status scales, assessing patients' suitability for cancer treatment, have limited ability to account for multimorbidity, frailty and cognition. The Clinical Frailty Scale (CFS) is a suggested alternative, but research detailing its use in oncology is limited. This study aims to evaluate if CFS is associated with prognosis and care needs on discharge in oncology inpatients. METHODS: We evaluated a large, single-centre cohort study in this research. CFS was recorded for adult inpatients at a Regional Cancer Centre. The associations between CFS, age, tumour type, discharge destination and care requirements and survival were evaluated. RESULTS AND CONCLUSIONS: A total of 676 patients were included in the study. Levels of frailty were high (Median CFS 6, 81.8% scored ≥5) and CFS correlated with performance status (R = 0.13: P = 0.047). Patients who were frail (CFS ≥ 5) were less likely to be discharged home (62.9%) compared with those who were not classed as frail (86.1%) (OR 3.6 [95%CI 2.1 to 6.3]: P < 0.001). Higher CFS was significantly associated with poorer prognosis in all ages. Solid organ malignancy (hazard ratio [HR] 2.60 [95%CI 2.05-3.32]) and CFS (HR 1.43 [95%CI 1.29-1.59]; P < 0.001) were independently associated with poorer survival. This study demonstrated that CFS may help predict prognosis in adult oncology inpatients of any age. This may aid informed shared decision-making in this setting. Future work should establish if routine CFS measurement can aid the appropriate prescription of systemic therapy and enable early conversations about discharge planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyAdultAgedHumansPatient DischargeCohort StudiesFrail ElderlyInpatientsPrognosis

Stichwörter der Autor:innen

allied health personnelcancerfrailtypalliative carepatient dischargeprognosis

Autor:innen und Institutionen

  • Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Department of Respiratory Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Population Health Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • St Oswald's Hospice, Newcastle upon Tyne, UK.

ORCID-Profile: Hannah Lowe

Förderung

  • Sir Bobby Robson Foundation
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust cancer charity
  • NIHR Newcastle Biomedical Research Centre

Zitieren

APA

Welford, J., Rafferty, R., Hunt, K., Short, D., Duncan, L., Ward, A., Rushton, C., Todd, A., Nair, S., Hoather, T., Clarke, M., Dawes, L., Anderson, V., Pelham, A., Lowe, H., Dewhurst, F., & Greystoke, A. (2022). The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato‐oncology inpatients: A cohort study. European Journal of Cancer Care, 31(6). https://doi.org/10.1111/ecc.13752

Vancouver

Welford J, Rafferty R, Hunt K, Short D, Duncan L, Ward A, et al. The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato‐oncology inpatients: A cohort study. European Journal of Cancer Care. 2022;31(6). doi:10.1111/ecc.13752

BibTeX
@article{Welford2022,
  author = {Welford, Jenny and Rafferty, Raigan and Hunt, Katherine and Short, David and Duncan, Louise and Ward, Ann and Rushton, Christine and Todd, Adam and Nair, Smeera and Hoather, Thomas and Clarke, Miranda and Dawes, Lydia and Anderson, Victoria and Pelham, Anne and Lowe, Hannah and Dewhurst, Felicity and Greystoke, Alastair},
  title = {The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato‐oncology inpatients: A cohort study},
  journal = {European Journal of Cancer Care},
  year = {2022},
  volume = {31},
  number = {6},
  doi = {10.1111/ecc.13752}
}
Kostenlos starten →